IRMD - IRadimed Corporation
NEXT EARNINGS:
Apr 24, 2026
EPS Est: $0.45
|
Rev Est: $21.3M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$120.00
DETAILS
HIGH:
$120.00
LOW:
$120.00
MEDIAN:
$120.00
CONSENSUS:
$120.00
UPSIDE:
21.10%
Market Cap:
1.26B
Volume:
53,657
Avg Volume:
78,375
52 Week Range:
47.478-107.9
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.14
Last Dividend:
$1.18
Exchange:
NASDAQ
Country:
US
Employees:
160
IPO Date:
2014-07-16
EPS (TTM):
1.77
P/E Ratio:
55.05
Revenue (TTM):
83.81M
Total Assets:
108.78M
Total Debt:
N/A
Cash & Equiv:
51.16M
Rev Growth (5Y):
21.5%
EPS Growth (5Y):
74.3%
FCF Growth (5Y):
12.6%
ROCE:
26.5%
Debt/Equity:
N/A
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-10 | $0.54 | $0.49 | +10.2% | $22.7M | $21.0M | +8.1% |
| 2025-11-03 | $0.47 | $0.48 | -2.1% | $21.2M | $21.6M | -1.8% |
| 2025-08-01 | $0.49 | $0.45 | +8.9% | $20.4M | $20.5M | -0.4% |
| 2025-05-05 | $0.42 | $0.43 | -2.3% | $19.5M | $19.3M | +0.9% |
| 2025-02-13 | $0.44 | $0.45 | -2.2% | $19.4M | $19.2M | +1.0% |
| 2024-10-31 | $0.43 | $0.39 | +10.3% | $18.3M | $18.9M | -3.2% |
| 2024-08-01 | $0.42 | $0.37 | +13.5% | $17.9M | $17.6M | +1.6% |
| 2024-05-02 | $0.36 | $0.34 | +5.9% | $17.6M | $17.1M | +2.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 83.81M | 73.24M | 65.56M | 53.30M | 41.81M | 31.72M | 38.52M | 30.44M | 23.08M | 32.50M | 31.59M | 15.65M |
| Net Income | 22.48M | 19.23M | 17.19M | 12.83M | 9.33M | 1.37M | 9.63M | 6.30M | 499,764 | 7.21M | 7.53M | 2.05M |
| EPS | 1.77 | 1.52 | 1.36 | 1.02 | 0.76 | 0.11 | 0.85 | 0.52 | 0.05 | 0.67 | 0.68 | 0.23 |
| Total Assets | 108.78M | 98.33M | 92.16M | 85.51M | 82.88M | 71.07M | 66.73M | 48.44M | 39.01M | 37.19M | 35.24M | 23.31M |
| Total Debt | 0 | 154,688 | 2.04M | 2.21M | 2.48M | 2.72M | 2.96M | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 51.16M | 52.23M | 49.76M | 57.96M | 62.00M | 50.07M | 43.48M | 28.03M | 18.21M | 17.71M | 19.37M | 9.45M |
| Operating Cash Flow | N/A | 25.62M | 13.47M | 10.04M | 11.26M | 5.82M | 10.23M | 7.38M | 3.42M | 9.41M | 7.65M | 2.59M |
| Free Cash Flow | N/A | 17.62M | 5.46M | 8.17M | 10.52M | 5.18M | 9.75M | 7.11M | 2.59M | 7.88M | 7.33M | 1.98M |
| FCF per Share | N/A | 1.39 | 0.43 | 0.65 | 0.85 | 0.43 | 0.86 | 0.59 | 0.24 | 0.73 | 0.67 | 0.23 |
| Book Value | 94.62M | 86.82M | 71.42M | 73.67M | 72.17M | 61.38M | 55.52M | 41.95M | 32.93M | 31.89M | 31.93M | 20.89M |
| Cash & ST Investments | 51.16M | 52.23M | 49.76M | 57.96M | 62.50M | 51.98M | 46.25M | 34.38M | 26.34M | 25.68M | 26.97M | 17.37M |
| ROC Equity | 0.24 | 0.22 | 0.24 | 0.17 | 0.13 | 0.02 | 0.17 | 0.15 | 0.02 | 0.23 | 0.24 | 0.10 |